Site Search
Professionals 449 results
Capabilities 78 results
Practice Area
Our structured finance group is widely recognized as a leader, encompassing Esoteric Finance, Residential Asset Finance and Securitization, and CLOs/Fund Finance. Positioned prominently at the forefront of the industry, our team boasts extensive experience across a broad spectrum of assets, with a particular focus on bespoke structures and emerging and/or “esoteric” assets, including residential and commercial PACE, RMBS, and CMBS; aircraft, vessel, and railcar finance; FinTech and marketplace lending; CLOs; specialty finance; consumer and business lending; energy structured finance (including solar finance and reserve-based finance); derivatives and structured products; lease and operating asset finance; trade receivables; litigation settlement financing; and life settlements.
Practice Area
Keeping a deal moving forward can be challenging. Our 100+ Finance attorneys help clients maintain momentum with a commitment to understanding the challenges, risks, and opportunities they face. Our global team has developed great insights through the representation of financial institutions and corporate enterprises of all types and sizes in the finance industry. We have a well-rounded finance practice, with dedicated teams that advise banks, credit funds, alternative capital providers, sponsors, and corporations on a wide range of transactions including debt finance (leveraged, asset-based, and reserve-based lending), fund finance, structured finance, derivatives and structured products, project finance, and transportation finance.
Practice Area
Experience 115 results
Experience
|September 9, 2025
Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms.
Experience
|August 18, 2025
Winston Represented Amphenol in Definitive Agreement to Acquire Trexon
Winston represented Amphenol Corporation (NYSE: APH), one of the world’s largest designers, manufacturers, and marketers of electrical, electronic, and fiber optic connectors and systems, as well as coaxial and high-speed specialty cables, in its definitive agreement to acquire Trexon, a leading provider of high-reliability interconnect and cable assemblies primarily serving the defense market. The acquisition is valued at approximately US$1B, subject to customary post-closing adjustments. Amphenol will finance the transaction with cash on hand and expects to close in the fourth quarter of 2025.
Experience
|June 3, 2025
Represented NTE Mobility Partners Segments 3 LLC (NTE3), the concession company operating, maintaining, and collecting tolls on the North Tarrant Express Segments 3A, 3B, and 3C Facility in Fort Worth, Texas (the Project), in connection with a senior financing consisting of approximately $457 million of senior forward delivery bonds. NTE3 will issue these bonds in three series, the proceeds of which will be applied, among other things, to the repayment of a portion of existing debt related to the construction of the Project.
Insights & News 1,955 results
Seminar/CLE
|September 18, 2025
Winston Hosts New York Financial Services Symposium
Winston’s Financial Services Industry Group is pleased to host our inaugural Financial Services Symposium in our New York office on Thursday, September 18, 2025. This event will include a half-day of programming led by top industry thought leaders. Below you will find details about each panel.
Recognitions
|September 11, 2025
|Less Than 1 Min Read
Winston Partners Featured as Leaders in Law in The Secured Lender
Winston & Strawn partners Jordan Klein and Jason Bennett have been recognized in the September issue of The Secured Lender as Leaders in Law. This annual feature highlights the indispensable role attorneys play in shaping the secured finance industry—serving not only as advisors, but also as architects of the frameworks that allow businesses to access and deploy capital.
In the Media
|September 9, 2025
|1 Min Read
Winston & Strawn partner Chris Gavin spoke with Private Debt Investor to provide his insights into the evolving regulatory landscape surrounding residential transition loans (RTLs). With the ongoing challenges of building enough homes to keep pace with the demand in the U.S. housing market, private lenders are turning to residential transition loans, short-term bridge, construction, or renovation financing for real estate investors, to find new opportunities in the complex housing market.
Other Results 45 results
Site Content
ESG in finance can refer to, among other things, financing tools such as Green, Social, and Sustainability Bonds and similar ESG-related debt instruments, as well as the separate discipline of ESG Investing. ESG stands for Environmental, Social, and Governance. Investors are increasingly applying these non-financial factors as part of their analysis to identify ESG-related risks and opportunities in particular investments. ESG metrics have not historically been included in financial reporting, though companies are increasingly making disclosures in their annual report or in a standalone sustainability report, and regulatory requirements for such disclosures, including from the SEC, are expanding.
Site Content
Definitions of big data may differ within the computing or business world. In general, the term refers to structured and unstructured data that is extremely large in volume and/or complex—and due to these characteristics, it is difficult to manage with standard data processing or storage. The phrase “big data” may also refer to the processing techniques that an organization employs to manage the huge, complex, or time-sensitive sets of information it receives.
Law Glossary
How Does an Applicant Establish Biosimilarity?
An applicant typically demonstrates biosimilarity based on non-clinical analyses that focus on the structure and functional differences between the biosimilar and reference product.